Jafron Biomedical Co.Ltd
300529StockSHE
16.74 ▲ +1.45%
12 juin 2026
3
Jafron Biomedical Co.Ltd
16.74 ▲ +1.45%
12 juin 2026
300529StockSHE

01 / À propos

Jafron Biomedical Co.,Ltd. engages in the research, development, production, and sale of blood purification products for hemadsorption field worldwide. The company offers therapies for kidney, liver, and critical diseases, as well as poisoning. It also provides HA series disposable hemoperfusion cartridge; BS series disposable plasma bilirubin perfusion adsorption column; blood purification machine; and other products, such as JM hemodialyzer, DNA230, disinfectant, hemodialysis concentrate, resin bandage, online hemodialysis B powder bag/bucket, PGA absorbable suture with needle, syringe and infusion pumps. The company was founded in 1989 and is based in Zhuhai, China.

Arberion
Loading market data